<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-C
Report by Issuer of Securities Quoted on NASDAQ
Interdealer Quotation System
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
Response Oncology, Inc.
- --------------------------------------------------------------------------------
(Exact name of Issuer as specified in charter)
1775 Moriah Woods Blvd., Memphis, TN 38117
- --------------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code 901-761-7000
--------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
1. Title of security Common Stock
----------------------------------------------------------
2. Number of shares outstanding before the change 34,932,615
-----------------------------
3. Number of shares outstanding after the change 6,986,523 (Approximate)
------------------------------
4. Effective date of change November 2, 1995
---------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
reverse split
----------------------------------------------------------------------
Give brief description of transaction decrease number of authorized
-----------------------------------
shares from 60,000,000 shares, $.002 par value, to 30,000,000 shares, $.01 par
- -------------------------------------------------------------------------------
value, with a corresponding reclassification to which each issued and
- -------------------------------------------------------------------------------
outstanding share will be reclassified, converted, and charged into
- -------------------------------------------------------------------------------
one-fifth (1/5) of an issued and outstanding share. Fractional shares to be
- -------------------------------------------------------------------------------
redeemed for cash.
- -------------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change Response Technologies, Inc.
-------------------------------------------------------
2. Name after change Response Oncology, Inc.
----------------------------------------------------------
3. Effective date of charter amendment changing name November 2, 1995
---------------------------
4. Date of shareholder approval of change, if required November 1, 1995
------------------------
Date 11/6/95
-------
/s/ Daryl P. Johnson, Chief Financial Officer
---------------------------------------------
(Officer's signature & title)
